Home > Boards > Canadian > Biotechs >

Trillium Therapeutics Inc. (TRIL)

Add TRIL Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 12/26/2018 2:59:35 PM - Followers: 41 - Board type: Free - Posts Today: 0

Trillium Therapeutics Inc. (NASDAQ:TRIL, TSX:TR)

Home: http://trilliumtherapeutics.com/trillium-home/default.aspx


Trillium Therapeutics Inc. 
2488 Dunwin Drive 
Mississauga, Ontario, 
Canada L5L 1J9 
Tel: +1 416.595.0627


Trillium Therapeutics Inc. is a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. The company’s lead program, SIRPaFc (TTI-621), is a fusion protein that consists of the CD47-binding domain of human SIRPa linked to the Fc region of a human immunoglobulin (IgG1). It is designed to act as a soluble decoy receptor, preventing CD47 from delivering its inhibitory (“do not eat”) signal. Neutralization of the inhibitory CD47 signal enables the activation of macrophage anti-tumor effects by pro-phagocytic (“eat”) signals. A Phase 1 clinical trial (NCT02663518) evaluating SIRPaFc is ongoing. Trillium also has a proprietary medicinal chemistry platform, using unique fluorine chemistry, which permits the creation of new chemical entities from validated drugs and drug candidates with improved pharmacological properties. Stemming from this platform, the company’s most advanced preclinical program is an orally-available bromodomain inhibitor, followed by an epidermal growth factor receptor antagonist with increased uptake in the brain. In addition, a number of compounds directed at undisclosed immuno-oncology targets are currently in the discovery phase. 


SEC filings:  http://www.nasdaq.com/symbol/tril/sec-filings


Twitter:  https://twitter.com/search?q=%24TRIL&src=ctag


Quote:  https://www.google.com/finance?q=NASDAQ%3ATRIL&ei=dWJkV-kHiKV5wPiX4As


Canadian Insider:  https://www.canadianinsider.com/company?menu_tickersearch=tr

Currency Converter: http://www.bankofcanada.ca/en/rates/converter.html

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.


Last update 6/17/2016


Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
TRIL News: Amended Statement of Ownership (sc 13g/a) 01/10/2019 03:40:29 PM
TRIL News: Statement of Ownership (sc 13g) 12/21/2018 04:05:16 PM
TRIL News: Report of Foreign Issuer (6-k) 12/03/2018 07:01:36 AM
TRIL News: Trillium Therapeutics Provides Update on its Intratumoral TTI-621 Program at the American Society of Hematology 60th Annual M... 12/03/2018 07:00:00 AM
TRIL News: Report of Foreign Issuer (6-k) 11/14/2018 07:02:30 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#575   They haven't been active on this or any jondoeuk 12/26/18 02:59:34 PM
#574   When is the company due to run low RUL6T2 12/07/18 03:40:21 PM
#573   NY1972, you still here in $TRIL?? LongRun8 11/09/18 10:22:03 PM
#572   ASH abstract https://ash.confex.com/ash/2018/webprogram/Paper116915.html jondoeuk 11/03/18 06:29:03 PM
#571   Updated data from the intratumoral trial in those jondoeuk 09/08/18 11:40:24 AM
#570   TRIL is in a world of hurt... biotech_researcher 07/24/18 03:10:49 PM
#569   Out @ $5.70 for small gain. Took advantage chmcnfunds 07/18/18 02:22:57 PM
#568   In @ $%.50. Could have done better if chmcnfunds 07/16/18 11:58:17 AM
#567   Bollinger band Volatility Squeeze in the making watch stockboy 03/09/18 08:10:43 AM
#566   TRIL. Liked the targeted science over the last biotech_researcher 12/13/17 01:37:20 PM
#565   Got out a few days ago...didn't and still catty 12/01/17 02:03:35 PM
#564   Re Other non-cancer indications for anti-CD47 NASH: It's Fibrosis, LongRun8 11/24/17 08:58:54 PM
#563   smmallbio: thx. Hope you're enjoying your Thanksgiving catty 11/23/17 04:33:48 PM
#562   It is still at little over $100M market cap. smallbio 11/23/17 12:09:43 AM
#561   Big question now is when to sell?????????? catty 11/22/17 11:20:39 AM
#560   have been following TRIL and just got in catty 11/01/17 01:31:02 PM
#559   Ladeburg on TRIL on ASH smallbio 10/27/17 08:25:08 PM
#558   If you are long TRIL, you want to NY1972 10/19/17 04:58:20 PM
#557   More interesting data: NY1972 10/19/17 04:14:07 PM
#556   I'm still shocked tril hasn't partnered yet. I ronpopeil 10/18/17 02:05:41 PM
#555   Here is the complete result: NY1972 10/18/17 01:50:42 PM
#554   Is there any additional data you can share? Thanks jondoeuk 10/18/17 10:34:11 AM
#553   I copied & pasted from EORTC poster. Your NY1972 10/18/17 09:53:42 AM
#552   I came across something slightly different (see post# 549). jondoeuk 10/18/17 05:43:01 AM
#551   You have to believe big pharma is watching. ronpopeil 10/17/17 10:11:48 PM
#550   From 1 abstract: NY1972 10/17/17 10:02:07 PM
#549   I came across the following (the link appears jondoeuk 10/17/17 09:32:57 AM
#548   The anti-tumor effect of radiation therapy is enhanced jondoeuk 09/23/17 08:06:56 AM
#547   Growth Equity Opportunities V, LLC has filed a wiltonio 06/09/17 04:41:27 PM
#546   TRILLIUM EXPANDS CLINICAL TRIAL WITH TTI-621 TO INCLUDE jondoeuk 06/07/17 01:22:15 PM
#545   Nothing new from Trillium but here is the jondoeuk 06/06/17 07:15:45 PM
#544   Cormorant Asset Management, LLC has filed a new wiltonio 06/05/17 04:19:02 PM
#543   Every one of my bio stocks are down smallbio 05/17/17 01:58:08 PM
#542   This is 2013 news? smallbio 05/15/17 09:58:02 AM
#541   “A research team from Stanford University’s School of DFRAI 05/13/17 12:13:20 PM
#540   Anti CD47 reverses fibrosis seschm 04/18/17 07:13:36 AM
#539   Comment from Biomaven: NY1972 04/04/17 06:59:26 PM
#538   Assessment of Minimal Residual Disease in Standard-Risk AML NY1972 04/03/17 11:28:52 PM
#537   TRIL took a lot of hits for on NY1972 04/03/17 11:12:00 AM
#536   In the TTI-621/rituximab combination cohort, 3 of 6 NY1972 04/03/17 10:41:48 AM
#535   We're up 28% from the mid 4's, I datatap 02/07/17 01:56:11 AM
#534   What happened to this stock diddobuyer 02/02/17 10:59:30 AM
#533   Its been brutal alright. Seems there are DFRAI 02/01/17 12:47:25 PM
#532   This stock is brutal. $4s coming ronpopeil 01/19/17 03:32:04 PM
#531   Still here holding.... DFRAI 01/17/17 11:09:19 AM
#530   Are you still in this one? Stock looks terrible ronpopeil 01/12/17 10:47:19 AM
#529   Tax loss selling, uninformed people selling etc compounding DFRAI 12/14/16 06:15:58 PM
#528   Everyone gone now? Looks like many people I ronpopeil 12/13/16 08:27:31 PM
#527   Several retail guys I know where we long ronpopeil 12/08/16 01:55:02 PM
#526   I am retail...have not sold and you indicated DFRAI 12/08/16 01:22:38 PM